Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

A Novel Role of LKB1 in Erythroblast Enucleation

Yuanlin Xu, Jingxin Zhang, Yan Li, Huan Zhang, Peijun Jia, Yazhe Zhen, Wanxin Li, Tingting Zheng, Ying Zhang, Yihan Wang, Yilin Zhang, Yanyan Liu, Xiuli An, Shijie Zhang

Blood (2024) 144 (Supplement 1): 539.

https://doi.org/10.1182/blood-2024-209096

Published: 2024

Journal Articles

Phase Ib/IIa Study of Amulirafusp Alfa (IMM0306) in Combination with Lenalidomide in Patients with Relapsed or Refractory CD20-Positive B-Cell Non-Hodgkin's Lymphoma

Lijuan Deng, Yanyan Liu, Ningjing Lin, Zhihua Yao, Jiuyang Zhang, Wei Meng, Qiying Lu, Wenzhi Tian, Jun Zhu, Yuqin Song

Blood (2024) 144 (Supplement 1): 3033.

https://doi.org/10.1182/blood-2024-200539

Published: 2024

Journal Articles

Protein Arginine Methyltransferase 1 Expands and Mobilizes Immune Megakaryocytes and Generates Hyperactive Platelets in Stress Conditions

Peipei Zhang, Anlun Li, Yanyan Liu, X. Long Zheng, Xinyang Zhao

Blood (2024) 144 (Supplement 1): 1164.

https://doi.org/10.1182/blood-2024-208526

Published: 2024

Journal Articles

Preliminary Results of a Phase Ⅱ Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma

Shuna Yao, Zhihua Yao, Zheng Yan, Haiying Wang, Junfeng Chu, Shuang Zhao, Xinyang Zhao, Yanyan Liu

Blood (2023) 142 (Supplement 1): 1758.

https://doi.org/10.1182/blood-2023-189345

Published: 2023

Journal Articles

Phase II Clinical Trial of R-CHOP Combined with Lenalidomide in the First-Line Treatment for Patients with High Risk Diffuse Large B Cell Lymphoma

Shuang Zhao, Jiuyang Zhang, Zheng Yan, Yuanlin Xu, Zhihua Yao, Junfeng Chu, Shuna Yao, Haiying Wang, Wenping Zhou, Xufeng Luo, Peipei Zhang, Yanyan Liu

Blood (2023) 142 (Supplement 1): 6237.

https://doi.org/10.1182/blood-2023-185955

Published: 2023

Journal Articles

Selective PI3Kδ Inhibitor Parsaclisib Combined with HDAC Inhibitor Chidamide in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Preliminary Results of a Phase Ib/Ⅱ Study

Zheng Yan, Shuna Yao, Shuang Zhao, Haiying Wang, Junfeng Chu, Yuanlin Xu, Jiuyang Zhang, Lina Zhang, Quande Lin, Lijie Liang, Ping Wang, Wenyong Li, Xiaolu Teng, Zhihua Yao, Yanyan Liu

Blood (2023) 142 (Supplement 1): 3075.

https://doi.org/10.1182/blood-2023-185902

Published: 2023

Journal Articles

Real-World Study of Polatuzumab Vedotin-Based Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Chinese Cohort: Updated Results of 2-Year Follow-up

Jianqiu Wu, Fei Li, Zhi-Jun Wuxiao, Weiyan Tang, Yue Teng, Yanyan Liu, Han Chu, Zhiya Wu, Yiwen Shen, Fancong Kong, Zhihua Yao, Weilun Zhou, Jifeng Feng

Blood (2023) 142 (Supplement 1): 6265.

https://doi.org/10.1182/blood-2023-181831

Published: 2023

Journal Articles

Pirtobrutinib, a Non-Covalent (reversible) BTK Inhibitor, in Mantle Cell Lymphoma Patients Previously Treated with a Covalent BTK Inhibitor: Results from a China Phase 2 Study

Yuqin Song, Shuhua Yi, Haiyan Yang, Ru Feng, Huiqiang Huang, Qingyuan Zhang, Yanyan Liu, Ye Guo, Huilai Zhang, Liling Zhang, Yijiao Qian, JianKun Zhu, Jun Zhu

Blood (2023) 142 (Supplement 1): 3636.

https://doi.org/10.1182/blood-2023-173287

Published: 2023

Journal Articles

Preliminary Results of a Phase Ⅱ Study of Zanubrutinib Combined with Immunochemotherapy in Patients with CD79A/CD79B-Mutant Diffuse Large B-Cell Lymphoma

Zhihua Yao, Zheng Yan, Shuna Yao, Haiying Wang, Junfeng Chu, Shuang Zhao, Jie Ma, Bing Wei, Jiawen Zheng, Quande Lin, Zheng Xu, Xinyang Zhao, Yanyan Liu

Blood (2022) 140 (Supplement 1): 3767–3768.

https://doi.org/10.1182/blood-2022-165944

Published: 2022

Journal Articles

Phase II Clinical Trial of Camrelizumab Combined with AVD (Epirubicin, Vincristine and Dacarbazine) in the First-Line Treatment for Patients with Advanced Classical Hodgkin's Lymphoma

Shuang Zhao, Yanyan Liu, Zhihua Yao, Zheng Yan, Shuna Yao, Junfeng Chu, Haiying Wang, Jiuyang Zhang, Peipei Zhang, Wenping Zhou

Blood (2022) 140 (Supplement 1): 6579–6580.

https://doi.org/10.1182/blood-2022-166829

Published: 2022

Journal Articles

A Multicenter Real-Life Study of Polatuzumab Vedotin Combined with Immunochemotherapy in Patients with R/R DLBCL: Preliminary Data on Efficacy and Safety in Chinese Cohort

Jianqiu Wu, Yanyan Liu, Li Fei, Zhi-Jun Wuxiao, Fancong Kong, Zhihua Yao, Weilun Zhou, Jifeng Feng

Blood (2020) 136 (Supplement 1): 50–51.

https://doi.org/10.1182/blood-2020-142553

Published: 2020

Journal Articles

Targeting PARP1 As an Effective Treatment for Diffuse Large B-Cell Lymphoma with High Level of γH2AX

Yanyan Liu, Peipei Zhang, Jiuyang Zhang, Wenping Zhou, Jialin Ma, Xinyang Zhao, PhD

Blood (2018) 132 (Supplement 1): 5799.

https://doi.org/10.1182/blood-2018-99-117590

Published: 2018

Journal Articles

The TAL1 Short Isoform Generated By PRMT1-Mediated Alternative RNA Splicing Promotes Erythroid Differentiation

Shuiling Jin, MD, Ngoc-Tung Tran, PhD, Hairui Su, BS, Suming Huang, PhD, Xinyang Zhao, PhD, Yanyan Liu, MDand PhD

Blood (2016) 128 (22): 1249.

https://doi.org/10.1182/blood.V128.22.1249.1249

Published: 2016

Journal Articles

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

Blood (2015) 125 (7): 1137–1145.

https://doi.org/10.1182/blood-2014-04-566778

Published: 2015

Includes: Supplemental data

Journal Articles

Arginine Methylation Of RBM15 By PRMT1 Controls Alternative Splicing Of Genes Involved In Megakaryocyte Differentiation

Xinyang Zhao, PhD, Li Zhang, Rui Wang, Ph.D., Ngoc Tung Trans, Hairui Su, Omar Abdel-Wahab, MD, Todd Hrick, Ross L. Levine, MD, Haiteng Deng, Ph.D., Yanyan Liu, MD, Yujun Zheng, Ph.D., Minkui Luo, Ph.D.

Blood (2013) 122 (21): 2443.

https://doi.org/10.1182/blood.V122.21.2443.2443

Published: 2013

Journal Articles

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

Blood (2012) 119 (21): 4939–4948.

https://doi.org/10.1182/blood-2011-07-370122

Published: 2012

Includes: Supplemental data

Journal Articles

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

Blood (2012) 119 (16): 3757–3766.

https://doi.org/10.1182/blood-2011-05-349662

Published: 2012

Includes: Supplemental data

Journal Articles

SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment

Bo Huang, Zhang Lei, Gui-Mei Zhang, Dong Li, Chuanwang Song, Bo Li, Yanyan Liu, Ye Yuan, Jay Unkeless, Huabao Xiong, Zuo-Hua Feng

Blood (2008) 112 (4): 1269–1279.

https://doi.org/10.1182/blood-2008-03-147033

Published: 2008

Includes: Supplemental data

NARROW

A Novel Role of LKB1 in Erythroblast Enucleation

Phase Ib/IIa Study of Amulirafusp Alfa (IMM0306) in Combination with Lenalidomide in Patients with Relapsed or Refractory CD20-Positive B-Cell Non-Hodgkin's Lymphoma

Protein Arginine Methyltransferase 1 Expands and Mobilizes Immune Megakaryocytes and Generates Hyperactive Platelets in Stress Conditions

Preliminary Results of a Phase Ⅱ Study of Lenalidomide Combined with Immunochemotherapy in Patients with Primary Central Nervous System Lymphoma

Phase II Clinical Trial of R-CHOP Combined with Lenalidomide in the First-Line Treatment for Patients with High Risk Diffuse Large B Cell Lymphoma

Selective PI3Kδ Inhibitor Parsaclisib Combined with HDAC Inhibitor Chidamide in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Preliminary Results of a Phase Ib/Ⅱ Study

Real-World Study of Polatuzumab Vedotin-Based Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Chinese Cohort: Updated Results of 2-Year Follow-up

Pirtobrutinib, a Non-Covalent (reversible) BTK Inhibitor, in Mantle Cell Lymphoma Patients Previously Treated with a Covalent BTK Inhibitor: Results from a China Phase 2 Study

Preliminary Results of a Phase Ⅱ Study of Zanubrutinib Combined with Immunochemotherapy in Patients with CD79A/CD79B-Mutant Diffuse Large B-Cell Lymphoma

Phase II Clinical Trial of Camrelizumab Combined with AVD (Epirubicin, Vincristine and Dacarbazine) in the First-Line Treatment for Patients with Advanced Classical Hodgkin's Lymphoma

A Multicenter Real-Life Study of Polatuzumab Vedotin Combined with Immunochemotherapy in Patients with R/R DLBCL: Preliminary Data on Efficacy and Safety in Chinese Cohort

Targeting PARP1 As an Effective Treatment for Diffuse Large B-Cell Lymphoma with High Level of γH2AX

The TAL1 Short Isoform Generated By PRMT1-Mediated Alternative RNA Splicing Promotes Erythroid Differentiation

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma

Arginine Methylation Of RBM15 By PRMT1 Controls Alternative Splicing Of Genes Involved In Megakaryocyte Differentiation

Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis

Molecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profiling

SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only